Liver transplantation for hepatocellular carcinoma

Area of Science:

• Hepatology
• Surgical Oncology
• Transplant Surgery

Background:

• Liver transplantation is a primary treatment for decompensated cirrhosis with small hepatocellular carcinoma.
• Resection is often not feasible in severe cirrhosis, making transplantation a vital option with high survival rates (70-80% 3-year).

Purpose of the Study:

• To evaluate the role of liver transplantation versus resection for hepatocellular carcinoma in patients with varying degrees of cirrhosis.
• To determine optimal treatment strategies for hepatocellular carcinoma based on tumor size, stage of liver disease, and patient candidacy.

Main Methods:

• Comparative analysis of outcomes for liver transplantation and surgical resection in hepatocellular carcinoma patients.
• Review of survival rates, recurrence rates, and tumor progression in different patient cohorts.

Main Results:

• Liver transplantation provides superior long-term outcomes compared to resection in patients with small hepatocellular carcinoma and compensated cirrhosis.
• Transplantation is contraindicated for large or multifocal tumors due to high recurrence and accelerated progression under immunosuppression.
• For hepatocellular carcinoma without underlying liver disease, resection is preferred, but transplantation is considered for unresectable or recurrent cases.

Conclusions:

• Liver transplantation is increasingly indicated for small hepatocellular carcinoma in compensated cirrhosis due to better long-term results.
• Patient selection is critical; large/multifocal tumors in cirrhotic patients are generally not transplant candidates.
• Minimizing recurrence risk is essential across all treatment modalities for hepatocellular carcinoma.